Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Decus Biomedical is a medical technology company based in San Carlos, California, specializing in the development of advanced interventional devices for oncology and vascular applications. The company's primary focus is on minimally invasive delivery systems, including proprietary microcatheters designed to improve the precision of embolization and localized drug delivery. Their technology is particularly aimed at treating hypervascular tumors, such as hepatocellular carcinoma, and complex vascular malformations. By optimizing the delivery of therapeutic agents, Decus Biomedical seeks to enhance clinical outcomes while minimizing systemic side effects for patients undergoing interventional procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Decus Biomedical.